Maxime Gualtiéri

1.1k total citations
25 papers, 705 citations indexed

About

Maxime Gualtiéri is a scholar working on Molecular Biology, Insect Science and Molecular Medicine. According to data from OpenAlex, Maxime Gualtiéri has authored 25 papers receiving a total of 705 indexed citations (citations by other indexed papers that have themselves been cited), including 14 papers in Molecular Biology, 9 papers in Insect Science and 8 papers in Molecular Medicine. Recurrent topics in Maxime Gualtiéri's work include Entomopathogenic Microorganisms in Pest Control (9 papers), Antibiotic Resistance in Bacteria (8 papers) and Insect symbiosis and bacterial influences (6 papers). Maxime Gualtiéri is often cited by papers focused on Entomopathogenic Microorganisms in Pest Control (9 papers), Antibiotic Resistance in Bacteria (8 papers) and Insect symbiosis and bacterial influences (6 papers). Maxime Gualtiéri collaborates with scholars based in France, United Kingdom and United States. Maxime Gualtiéri's co-authors include Jean‐Paul Léonetti, Philippe Villain-Guillot, Lionel Bastide, Konstantin Brodolin, André Aumelas, Jacques‐Olivier Thaler, Emilie Racine, Martine Pugnière, Zakia Morichaud and Françoise Roquet‐Banères and has published in prestigious journals such as The EMBO Journal, Journal of Medicinal Chemistry and Antimicrobial Agents and Chemotherapy.

In The Last Decade

Maxime Gualtiéri

24 papers receiving 675 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Maxime Gualtiéri France 15 304 160 150 119 109 25 705
Lucy Foulston United States 12 705 2.3× 51 0.3× 26 0.2× 93 0.8× 76 0.7× 12 1.0k
Shannon B. Falconer Canada 8 343 1.1× 269 1.7× 15 0.1× 52 0.4× 77 0.7× 9 703
Sibel Döşler Türkiye 13 474 1.6× 99 0.6× 82 0.5× 16 0.1× 115 1.1× 31 883
Andrea Schiefer Germany 13 127 0.4× 41 0.3× 113 0.8× 32 0.3× 23 0.2× 25 423
Valérie Dekimpe Canada 11 702 2.3× 295 1.8× 32 0.2× 262 2.2× 22 0.2× 12 934
Christelle Vogne Switzerland 11 428 1.4× 483 3.0× 62 0.4× 153 1.3× 11 0.1× 14 925
Anton F. Ehrhardt United States 13 263 0.9× 403 2.5× 48 0.3× 26 0.2× 73 0.7× 19 756
Angela M. Kavanagh Australia 11 442 1.5× 153 1.0× 26 0.2× 27 0.2× 130 1.2× 15 828
Laura Nunes Silva Brazil 12 291 1.0× 44 0.3× 49 0.3× 23 0.2× 73 0.7× 21 791
Anne Berscheid Germany 14 645 2.1× 108 0.7× 18 0.1× 73 0.6× 101 0.9× 23 1.1k

Countries citing papers authored by Maxime Gualtiéri

Since Specialization
Citations

This map shows the geographic impact of Maxime Gualtiéri's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Maxime Gualtiéri with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Maxime Gualtiéri more than expected).

Fields of papers citing papers by Maxime Gualtiéri

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Maxime Gualtiéri. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Maxime Gualtiéri. The network helps show where Maxime Gualtiéri may publish in the future.

Co-authorship network of co-authors of Maxime Gualtiéri

This figure shows the co-authorship network connecting the top 25 collaborators of Maxime Gualtiéri. A scholar is included among the top collaborators of Maxime Gualtiéri based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Maxime Gualtiéri. Maxime Gualtiéri is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
2.
Berg, Sanne van den, Marie Attwood, Anouk E. Muller, et al.. (2025). Pharmacodynamics of NOSO-502 studied in vitro and in vivo: determination of the dominant pharmacodynamic index driver. Journal of Antimicrobial Chemotherapy. 80(3). 752–759. 2 indexed citations
3.
Lanois, Anne, et al.. (2023). The AcrAB efflux pump confers self-resistance to stilbenes in Photorhabdus laumondii. Research in Microbiology. 174(7). 104081–104081. 4 indexed citations
4.
5.
Guérin, François, Marie Attwood, Alan Noel, et al.. (2022). Exploring Cluster-Dependent Antibacterial Activities and Resistance Pathways of NOSO-502 and Colistin against Enterobacter cloacae Complex Species. Antimicrobial Agents and Chemotherapy. 66(11). e0077622–e0077622. 12 indexed citations
6.
Fu, Jun, Jean-Claude Ogier, Yury S. Polikanov, et al.. (2022). The Odilorhabdin Antibiotic Biosynthetic Cluster and Acetyltransferase Self-Resistance Locus Are Niche and Species Specific. mBio. 13(1). e0282621–e0282621. 17 indexed citations
7.
Loža, Einārs, Mārtiņš Katkevičs, Victoria Ryabova, et al.. (2020). Structure-activity relationship studies on the inhibition of the bacterial translation of novel Odilorhabdins analogues. Bioorganic & Medicinal Chemistry. 28(11). 115469–115469. 5 indexed citations
8.
Racine, Emilie & Maxime Gualtiéri. (2019). From Worms to Drug Candidate: The Story of Odilorhabdins, a New Class of Antimicrobial Agents. Frontiers in Microbiology. 10. 2893–2893. 24 indexed citations
9.
Racine, Emilie, et al.. (2018). In Vitro and In Vivo Characterization of NOSO-502, a Novel Inhibitor of Bacterial Translation. Antimicrobial Agents and Chemotherapy. 62(9). 21 indexed citations
10.
Figueiredo, Renata Marcia de, et al.. (2018). Total Synthesis and Structure–Activity Relationships Study of Odilorhabdins, a New Class of Peptides Showing Potent Antibacterial Activity. Journal of Medicinal Chemistry. 61(17). 7814–7826. 22 indexed citations
11.
Aumelas, André, Thierry Noël, Sylvie Pagès, et al.. (2013). Cabanillasin, a new antifungal metabolite, produced by entomopathogenic Xenorhabdus cabanillasii JM26. The Journal of Antibiotics. 66(10). 617–620. 42 indexed citations
12.
Gualtiéri, Maxime, et al.. (2010). The transcription inhibitor lipiarmycin blocks DNA fitting into the RNA polymerase catalytic site. The EMBO Journal. 29(15). 2527–2537. 56 indexed citations
13.
Gualtiéri, Maxime, et al.. (2010). Resistance to rifampicin: at the crossroads between ecological, genomic and medical concerns. International Journal of Antimicrobial Agents. 35(6). 519–523. 85 indexed citations
14.
Gualtiéri, Maxime, et al.. (2009). Myxopyronin: A Punch in the Jaws of Bacterial RNA Polymerase. Future Microbiology. 4(2). 145–149. 8 indexed citations
15.
Gualtiéri, Maxime, André Aumelas, & Jacques‐Olivier Thaler. (2009). Identification of a new antimicrobial lysine-rich cyclolipopeptide family from Xenorhabdus nematophila. The Journal of Antibiotics. 62(6). 295–302. 70 indexed citations
16.
Gualtiéri, Maxime, et al.. (2008). The Antibiotics in the Chemical Space. Current Medicinal Chemistry. 16(3). 390–393. 14 indexed citations
17.
Villain-Guillot, Philippe, Lionel Bastide, Maxime Gualtiéri, & Jean‐Paul Léonetti. (2007). Progress in targeting bacterial transcription. Drug Discovery Today. 12(5-6). 200–208. 67 indexed citations
18.
Villain-Guillot, Philippe, Maxime Gualtiéri, Lionel Bastide, et al.. (2007). Structure−Activity Relationships of Phenyl-Furanyl-Rhodanines as Inhibitors of RNA Polymerase with Antibacterial Activity on Biofilms. Journal of Medicinal Chemistry. 50(17). 4195–4204. 68 indexed citations
19.
Villain-Guillot, Philippe, Maxime Gualtiéri, Lionel Bastide, & Jean‐Paul Léonetti. (2007). In Vitro Activities of Different Inhibitors of Bacterial Transcription against Staphylococcus epidermidis Biofilm. Antimicrobial Agents and Chemotherapy. 51(9). 3117–3121. 39 indexed citations
20.
Gualtiéri, Maxime. (2006). In vitro activity of a new antibacterial rhodanine derivative against Staphylococcus epidermidis biofilms. Journal of Antimicrobial Chemotherapy. 58(4). 778–783. 54 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Lucy Foulston Breakdown of academic impact, for papers by Shannon B. Falconer Breakdown of academic impact, for papers by Sibel Döşler Breakdown of academic impact, for papers by Andrea Schiefer Breakdown of academic impact, for papers by Valérie Dekimpe Breakdown of academic impact, for papers by Christelle Vogne Breakdown of academic impact, for papers by Anton F. Ehrhardt Breakdown of academic impact, for papers by Angela M. Kavanagh Breakdown of academic impact, for papers by Laura Nunes Silva Breakdown of academic impact, for papers by Anne Berscheid
Rankless by CCL
2026